Financial News Feed

Stronger Sell Today ADMP ranks #5448 as SELL CANDIDATE #5448 Weaker Sell

Adamis Pharmaceuticals Corporation stock forecast

ADMP stock forecast

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 29) Chiasma Inc (NASDAQ: CHMA ) Soliton Inc (NASDAQ: SOLY )( reacted to the news of the initiation of cellulite trial) Eidos Therapeutics Inc (NASDAQ: EIDX ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 29) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alkermes Plc (NASDAQ: ALKS ) Allena Pharmaceuticals Inc (NASDAQ: ALNA ) Allergan plc (NYSE: AGN ) AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) Aptinyx Inc (NASDAQ: APTX ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) CAN-FITE BIOPHA/S ADR (NYSE: CANF )(reacted to its first-quarter results and an update on clinical trial progress) Cidara Therapeutics Inc (NASDAQ: CDTX ) Diplomat Pharmacy Inc (NYSE: DPLO ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Emergent Biosolutions Inc (NYSE: EBS ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Hookipa Pharma Inc (NASDAQ: HOOK ) IMMURON LTD/S ADR (NASDAQ: IMRN ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Melinta Therapeutics Inc (NASDAQ: MLNT ) Opko Health Inc. (NASDAQ: OPK ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA )( downgraded by UBS to Neutral on its legal woes) Theravance Biopharma Inc (NASDAQ: TBPH ) Xenetic Biosciences Inc (NASDAQ: XBIO ) Stock In Focus Unity …...

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 21) Array Biopharma Inc (NASDAQ: ARRY ) (announced positive late-stage results for its colorectal cancer combo drug) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 21) Adamis Pharmaceuticals Corp (NASDAQ: ADMP )(announced a patent litigation against it for its naloxone injection product candidate that is currently under regulatory review) BioCryst Pharmaceuticals, Inc (NASDAQ: BCRX )( reacted to late-stage study data for its hereditary angioedema prevention candidate) Cancer Genetics Inc (NASDAQ: CGI ) (reacted to its first-quarter results) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Hookipa Pharma Inc (NASDAQ: HOOK ) (reacted to its first-quarter results) Ocular Therapeutix Inc (NASDAQ: OCUL ) ( reported negative Phase 3 readout for glaucoma treatment candidate) Theravance Biopharma Inc (NASDAQ: TBPH ) (reported Phase 1b data of its gut-selective pan-Janus kinase inhibitor TD-1473 at the Digestive Disease Week 2019) Trillium Therapeutics Inc (NASDAQ: TRIL ) Stock In Focus Tocagen's Brian Cancer Gene Therapy Trials Continue With Modification Tocagen Inc (NASDAQ: TOCA ) announced the Phase 3 trial evaluating its Toca 511 and Toca FC gene therapies in patients with recurrent high grade glioma continues without modification....

Read more

No summary available....

Read more

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today conditional acceptance by the U.S. Food and Drug Administration (FDA) of the proposed brand name for the company’s high dose naloxone product candidate. The notification to the company from the FDA noted that after review, the proposed...

Read more

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q1 2019 Results Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Dennis Carlo – President a...

Read more

Adamis (ADMP) delivered earnings and revenue surprises of -11.76% and -17.48%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?...

Read more

No summary available....

Read more

No summary available....

Read more

Adamis Pharmaceuticl (ADMP) shares are under scrutiny today as the Balance of Power has trended lower over multiple sessions. The Balance of Power is a simple indicator and it is used in technical ana...

Read more

Among 3 analysts covering Adamis Pharmaceuticals (NASDAQ:ADMP), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Adamis Pharmaceuticals had 5 analyst reports since November 12, 2018 a...

Read more

The primary goal for some beginner traders might be just trying to survive. Traders that are disciplined with their money management may be able to better ride out the bumps that come with inexperienc...

Read more

Brokerages expect that Adamis Pharmaceuticals Corp (NASDAQ:ADMP) will report ($0.15) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have ...

Read more

As Drug Delivery company, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) is competing with its rivals based on the risk, analyst recommendations, profitability, dividends, earnings and valuation, in...

Read more

Shares of Adamis Pharmaceuticl (ADMP) have been tilting lower over the past 13 weeks, revealing bearish momentum for the shares, as they have dipped -14.98% over the past quarter. Looking further out ...

Read more

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Ratings CoverageAmong 3 analysts covering Adamis Pharmaceuticals (NASDAQ:ADMP), 2 have Buy rating, 0 Sell and...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank